IBAB — Ion Beam Applications SA Share Price
Last trade - 00:00- €290.06m
- €261.36m
- €498.20m
- 69
- 37
- 27
- 37
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 9.47 | ||
| PEG Ratio (f) | 0.18 | ||
| EPS Growth (f) | 110.56% | ||
| Dividend Yield (f) | 2.92% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.62 | ||
| Price to Tang. Book | 3.4 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.58 | ||
| EV to EBITDA | 8.35 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.32% | ||
| Return on Equity | 8.57% | ||
| Operating Margin | 3.93% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 311.95 | 312.96 | 361.27 | 428.72 | 498.2 | 567.9 | 606.48 | 12.01% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -87.56 | +136.83 | n/a | n/a | +187.31 | +47.82 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.
Directors
- Pierre Mottet CHM
- Olivier Legrain CEO
- Soumya Chandramouli CFO
- Frederic Nolf CHO
- Yves Jongen CSO
- Christine Dubus IND
- Richard Hausmann IND (60)
- Hedvig Hricak IND
- Marcel Miller IND
- Sybille Van Den Hove IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 28th, 1986
- Public Since
- June 13th, 1998
- No. of Employees
- 1,844
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Euronext - Brussels
- Shares in Issue
- 29,181,437
- Address
- Chemin du Cyclotron 3, LOUVAIN-LA-NEUVE, 1348
- Web
- https://iba-worldwide.com
- Phone
- +32 10475811
- Auditors
- PricewaterhouseCoopers Reviseurs d'Entreprises SCC
Latest News for IBAB
Upcoming Events for IBAB
Q1 2025 Ion Beam Applications SA Earnings Release
Half Year 2025 Ion Beam Applications SA Earnings Release
Similar to IBAB
Agfa Gevaert NV
Euronext - Brussels
Biocartis NV
Euronext - Brussels
Nyxoah SA
Euronext - Brussels
Onward Medical NV
Euronext - Brussels
FAQ
As of Today at 21:12 UTC, shares in Ion Beam Applications SA are trading at €9.94. This share price information is delayed by 15 minutes.
Shares in Ion Beam Applications SA last closed at €9.94 and the price had moved by -24.01% over the past 365 days. In terms of relative price strength the Ion Beam Applications SA share price has underperformed the FTSE Global All Cap Index by -25.34% over the past year.
The overall consensus recommendation for Ion Beam Applications SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Ion Beam Applications SA dividend yield is 2.05% based on the trailing twelve month period.
Last year, Ion Beam Applications SA paid a total dividend of €0.20, and it currently has a trailing dividend yield of 2.05%. We do not have any data on when Ion Beam Applications SA is to next pay dividends.
We do not have data on when Ion Beam Applications SA is to next pay dividends. The historic dividend yield on Ion Beam Applications SA shares is currently 2.05%.
To buy shares in Ion Beam Applications SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €9.94, shares in Ion Beam Applications SA had a market capitalisation of €290.06m.
Here are the trading details for Ion Beam Applications SA:
- Country of listing: Belgium
- Exchange: BRU
- Ticker Symbol: IBAB
Based on an overall assessment of its quality, value and momentum Ion Beam Applications SA is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Ion Beam Applications SA is €16.20. That is 62.98% above the last closing price of €9.94.
Analysts covering Ion Beam Applications SA currently have a consensus Earnings Per Share (EPS) forecast of €0.92 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ion Beam Applications SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -29.29%.
As of the last closing price of €9.94, shares in Ion Beam Applications SA were trading -22.53% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Ion Beam Applications SA PE ratio based on its reported earnings over the past 12 months is 9.47. The shares last closed at €9.94.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Ion Beam Applications SA's management team is headed by:
- Pierre Mottet - CHM
- Olivier Legrain - CEO
- Soumya Chandramouli - CFO
- Frederic Nolf - CHO
- Yves Jongen - CSO
- Christine Dubus - IND
- Richard Hausmann - IND
- Hedvig Hricak - IND
- Marcel Miller - IND
- Sybille Van Den Hove - IND